Description: H.Amdt. 668 — 116th Congress (2019-2020)All Information (Except Text)

Amendment expands the prohibition of the Board of Directors from approving a transaction unless the person receiving the Agency's support certifies that the person does not engage in any activity in contravention of any U.S. law, regulation, or order concerning sanctions relating to the illegal trafficking of synthetic opioids, including any sanctions imposed pursuant to the Foreign Narcotics Kingpin Designation Act.

Purpose:

An amendment numbered 4 printed in House Report 116-289 to expand the prohibition of the Board of Directors from approving a transaction unless the person receiving the Agencys support certifies that the person does not engage in any activity in contravention of any U.S. law, regulation, or order concerning sanctions relating to the illegal trafficking of synthetic opioids, including any sanctions imposed pursuant to the Foreign Narcotics Kingpin Designation Act.

House Amendment Code:

(A004)

House Tally Clerks use this code to manage amendment information.